| Gene: | LILRB2 |
| GeneID: | ENSG00000131042 |
| Chrom: | 19 |
| Start position: | 54273812 |
| End position: | 54281184 |
| Pathway: | B cell receptor signaling pathway |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.136906 |
| Number of nsSNPs: | 14 |
| nsSNPs in gene: | rs386056 rs373032 rs383369 rs10405713 rs1128646 rs116027944 rs199893740 rs201144349 rs201709101 rs201954016 rs202225109 |
| Gene Structure: | ![]() |
|
Overall distribution |
Tissue specific distribution |
|||
|
|
|
|||
|
Overall distribution |
Tissue specific distribution |
|||||||
|
|
|||||||
|
Overall distribution |
Tissue specific distribution |
||||
|
|
||||
| Functional class: | Not specified |
| JensenLab PubMed score: | 85.41 (Percentile rank: 70.37%) |
| PubTator score: | 25.50 (Percentile rank: 56.65%) |
| Target development/druggability level: | TbioThese targets do not have known drug or small molecule activities that satisfy the activity thresholds detailed below AND satisfy one or more of the following criteria: 1) target is above the cutoff criteria for Tdark; 2) target is annotated with a Gene Ontology Molecular Function or Biological Process leaf term(s) with an Experimental Evidence code. |
| Tractability (small molecule): | N/A |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |